First Mercantile Trust Co. decreased its stake in shares of Intuitive Surgical Inc. (NASDAQ:ISRG) by 12.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,030 shares of the company’s stock after selling 150 shares during the period. First Mercantile Trust Co.’s holdings in Intuitive Surgical were worth $681,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in ISRG. PineBridge Investments L.P. raised its position in shares of Intuitive Surgical by 291.2% in the second quarter. PineBridge Investments L.P. now owns 16,571 shares of the company’s stock valued at $10,960,000 after buying an additional 12,335 shares in the last quarter. Westpac Banking Corp raised its position in shares of Intuitive Surgical by 2.8% in the second quarter. Westpac Banking Corp now owns 6,726 shares of the company’s stock valued at $4,449,000 after buying an additional 183 shares in the last quarter. Mizuho Asset Management Co. Ltd. raised its position in shares of Intuitive Surgical by 246.6% in the second quarter. Mizuho Asset Management Co. Ltd. now owns 863 shares of the company’s stock valued at $571,000 after buying an additional 614 shares in the last quarter. Vanguard Group Inc. raised its position in shares of Intuitive Surgical by 3.4% in the second quarter. Vanguard Group Inc. now owns 2,326,605 shares of the company’s stock valued at $1,538,841,000 after buying an additional 77,521 shares in the last quarter. Finally, CLS Investments LLC raised its position in shares of Intuitive Surgical by 2.0% in the second quarter. CLS Investments LLC now owns 1,559 shares of the company’s stock valued at $1,031,000 after buying an additional 31 shares in the last quarter. 91.90% of the stock is currently owned by institutional investors.

Intuitive Surgical Inc. (NASDAQ:ISRG) opened at 703.06 on Thursday. Intuitive Surgical Inc. has a one year low of $447.00 and a one year high of $720.01. The firm’s 50 day moving average price is $688.84 and its 200-day moving average price is $648.41. The firm has a market cap of $27.06 billion, a PE ratio of 39.90 and a beta of 0.73.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, July 19th. The company reported $5.62 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $4.97 by $0.65. The business had revenue of $670 million for the quarter, compared to analyst estimates of $640.69 million. Intuitive Surgical had a return on equity of 15.25% and a net margin of 26.80%. During the same quarter in the previous year, the company earned $4.57 EPS. Equities analysts predict that Intuitive Surgical Inc. will post $21.30 EPS for the current fiscal year.

Several brokerages recently issued reports on ISRG. Zacks Investment Research lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Tuesday. JPMorgan Chase & Co. reaffirmed a “buy” rating on shares of Intuitive Surgical in a research report on Tuesday. BTIG Research reaffirmed a “hold” rating on shares of Intuitive Surgical in a research report on Tuesday. Leerink Swann reiterated an “outperform” rating and set a $780.00 price target on shares of Intuitive Surgical in a research note on Monday. Finally, Raymond James Financial Inc. assumed coverage on Intuitive Surgical in a research note on Friday, August 26th. They set an “outperform” rating on the stock. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and thirteen have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $701.42.

In other news, Director Alan J. Levy sold 3,188 shares of the business’s stock in a transaction that occurred on Thursday, August 4th. The stock was sold at an average price of $694.11, for a total transaction of $2,212,822.68. Following the sale, the director now owns 5,401 shares of the company’s stock, valued at approximately $3,748,888.11. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Marshall Mohr sold 5,000 shares of the business’s stock in a transaction that occurred on Wednesday, July 27th. The stock was sold at an average price of $684.09, for a total value of $3,420,450.00. Following the sale, the chief financial officer now directly owns 6,725 shares in the company, valued at approximately $4,600,505.25. The disclosure for this sale can be found here. Insiders own 3.10% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

5 Day Chart for NASDAQ:ISRG

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical Inc. (NASDAQ:ISRG).

Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.